Message from Amanda Scott, NanoApps Medical CEO:
If you are reading this you probably searched for the Chakravarthy Lab website on google and noticed all links to the site go nowhere.
So you tried this link – since it appears in searches immediately under links to the non-existent website for Chakravarthy Lab.
Frank Boehm and NanoApps Medical Inc and Amanda Scott have NO relationship anymore with Dr Krishnan Chakravarthy and his Chakravarthy Lab San Diego.
We built his website, paid for the rights to use images and even made the site GDPR compliant. He didn’t pay his bill despite requesting an Invoice. He has since ignored all efforts to contact him and settle his account. Therefore, we regrettably repossessed his site and will refer this matter to debt collectors in San Diego.
Therefore, the following content – which was posted on July 2 2018 – is no longer valid.
There will be a further statement on this in due course.
You can reach me directly here at firstname.lastname@example.org should you require any explanation or clarification in the meantime.
Amanda Scott – CEO NanoApps Medical Inc
Published on July 2 2018:
The primary goals of the Chakravarthy Lab are to investigate the pathophysiology and mechanisms of chronic pain in the context of complex regional pain syndrome (CRPS), diabetic neuropathy, persistent postsurgical pain and neuropathic pain. Further, our lab focuses on how volatile anesthetics and various pain modulators affect host immunity to viral and bacterial infections.
Frank Boehm has been involved with nanotechnology and especially nanomedicine since 1996.
He initiated and serves as CEO of NanoApps Medical Incorporated. The aim of this company is to investigate and develop advanced, innovative, and cost effective nanomedical diagnostic and therapeutic devices and systems for the benefit of individuals in both the developing and developed worlds.
Frank is the author of Nanomedical Device and Systems Design: Challenges, Possibilities, Visions, which was published by CRC Press, and is currently generating two new books. He will serve as Industry Liaison for the Chakravarthay Lab, and work to facilitate and expedite the translation of advanced nanomedical technologies to commercialization on a global scale.
Visit the Chakravarthy Lab site.
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear: 1 June — Positive coronavirus test is no guarantee of infectiousness People [...]
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially been thought to largely affect the lungs in the form [...]
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. [...]
Rheumatologists at the University of Alberta are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to [...]
Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars [...]
In late December last year, Dr. Li Wenliang began warning officials about a novel coronavirus in Wuhan, China, but was silenced by the police before tragically succumbing to the [...]
Almost 10 weeks into the pandemic, COVID-19 is continuing to surprise and baffle health experts. In fact, experts' picture of exactly how COVID-19 might play out in the body [...]
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease [...]
Purple rashes, swollen legs, clogged catheters and sudden death — blood clots, large and small, are a frequent complication of COVID-19, and researchers are just beginning to untangle why. [...]
Coronavirus vaccine trials are underway around the world. China’s hoping it can be first for ‘redemption’
In a medical centre in the eastern city of Xuzhou, a few dozen healthy adults have become some of the first to trial a vaccine candidate for the coronavirus. [...]
A team of researchers hailing from Harvard and Université de Montréal today launched Epitopes.world, an AI-powered, interactive platform designed to facilitate COVID-19 vaccine development. It’s built atop an algorithm — CAMAP — [...]
The "Human Brain/Cloud Interface" paper had more views that 99% of Frontiers articles. It has now been added to Frontier's "Nanotechnologies in Neuroscience and Neuroengineering" ebook which is available [...]
This is the full-length version of this post. You can read the condensed version, which appeared as an opinion article in the Washington Post, here. The coronavirus pandemic pits all of [...]
European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes. Responding to the [...]
Understanding how COVID-19 attacks the human body is essential to developing an effective treatment or vaccine to stop the global pandemic — but there's still so much we don't know about how [...]
Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients [...]
A coronavirus strain isolated in India carried a mutation that could upend vaccine development around the globe, according to researchers from Australia and Taiwan. The non-peer reviewed study said [...]
Ivermectin shows promise as potential COVID-19 therapy. Summary: An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows [...]
Coronavirus hits the old and those with other health problems hardest, but fit, youthful people are dying too, and experts are trying to understand why: It remains one of [...]
he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood [...]
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness [...]
New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of [...]